SIGA Technologies, Inc.

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-19.4M
Depreciation & Amortization $475.1K
Depreciation —
Amortization —
Stock-Based Compensation $2.1M
Net Cash from Operating Activities $-8.5M
Investing Activities
Capital Expenditures $340.7K
Business Acquisitions —
Net Cash from Investing Activities $-5.3M
Financing Activities
Dividends Paid —
Stock Repurchases $0
Net Cash from Financing Activities $26.0M
Net Change in Cash $12.2M
Free Cash Flow $-8.8M
← Newer Page 3 of 3 Older →